Mark Miller, the executive vice president of health care at Arnold Ventures joins Dr. Josh Sharfstein to talk about the impact of the Inflation Reduction Act for Medicare patients this year, as well as two areas of future work to bring down the cost of prescription drugs. They discuss patent reform and opportunities to increase transparency for pharmaceutical benefit managers.